Tag: Opioids
Buprenorphine Rx Activity Varies Widely Among Clinicians
Less than 5 percent of prescribers account for half of all buprenorphine treatment in the country
Depot Buprenorphine Improves Outcomes in Opioid Dependence
Improvement seen in treatment satisfaction and several secondary end points for depot buprenorphine versus sublingual buprenorphine
Risk for Overdose Up With Opioid Prescriptions After Dental Procedure
Study finds increased risk for overdose among patients who fill an opioid prescription and their family members
Factors ID’d Putting Youth on High-Risk Trajectory After First Opioid Rx
Differences between the two trajectories persist in opioid fills, misuse beyond 12 months
FDA Approves Higher-Dose Naloxone Hydrochloride Nasal Spray
8-mg dose of naloxone hydrochloride nasal spray now approved with 2-mg and 4-mg doses
Younger Age at First Drug Use Tied to Faster Transition to Substance Use Disorder
Past-year substance use disorder higher for adolescents than young adults at all examined time frames since first use
ASA: Endocarditis, Related Strokes Up During Opioid Epidemic
Authors say known IV drug users who have infective endocarditis should be screened carefully for symptoms of cardiovascular disease
Opioid Discharge Prescription Guideline Satisfies Most Patients
93 percent of 229 patients undergoing surgery satisfied with guideline, which was based on their usage the day before discharge
Opioid Maker Purdue Pharma Files Bankruptcy Plan
Plan remakes company into a new corporation with revenue targeted exclusively at reducing the nation's opioid crisis
